Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights Hartmann TN; Pleyer L; Desch P; Egle A; Greil RDiscov Med 2009[Oct]; 8 (42): 157-64Chronic lymphocytic leukemia (CLL) is a malignancy mainly affecting elderly people and is still considered an incurable disease. Despite recent advances in CLL treatment, relapse rates are high and often accompanied by the development of resistance towards conventional chemotherapy. Thus, new agents are needed for the treatment of these patients. In recent years, our understanding of the biological mechanisms driving CLL pathogenesis has considerably improved, and novel treatment strategies are arising. This review summarizes recent insights in CLL biology and describes several new agents and treatment strategies that are currently explored in pre-clinical studies and early-phase clinical trials.|Antineoplastic Agents/therapeutic use[MESH]|Apoptosis/genetics/physiology[MESH]|Humans[MESH]|Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy/*metabolism[MESH]|Receptors, Antigen, B-Cell/metabolism[MESH]|Signal Transduction/drug effects/genetics/physiology[MESH] |